Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 0%
Sell 0%
Strong Sell 7%

Bulls say

HealthEquity is well-positioned to benefit from the growing trend of high-deductible healthcare plans, as seen in its strong fourth quarter and fiscal year results with growth in service revenue and total accounts. With investments in technology and security, the company aims to improve efficiency and reduce fraud, which is reflected in their strong cash flow and free cash flow. With strong growth in custodial revenue and raised guidance for the next fiscal year, HealthEquity has been rated as a Buy for its potential for future growth and improved financials.

Bears say

HealthEquity is experiencing strong growth in revenue and gross profit, driven by increased efficiency and a reduction in fraud costs. However, operating expenses are also on the rise, surpassing analyst estimates and potentially limiting profitability. The company is focusing on transformation and expanding its services to include a marketplace for various health solutions, but their reliance on HSAs may limit their long-term growth potential.

HealthEquity (HQY) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 0% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 14 analysts, HealthEquity (HQY) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $115.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $115.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.